QUOTED. Feb. 18, 2019. Michael Carome.
Executive Summary
At a recent meeting, a US FDA advisory committee cautioned the agency to very carefully consider risks and benefits prior to agency approval of any new pelvic mesh products. See what Public Citizen's Michael Carome said about it here.
“Thousands of women have been harmed, many permanently, by pelvic mesh. We urge the FDA to reject the PMA applications for the three products still on the market, effectively banning them." –Michael Carome, director, Public Citizen's Health Research Group
- Find out more: US FDA Advisory Committee Recommends 3-Year Benefit-Risk Reviews for Pelvic Mesh
Click here for a free trial of Medtech Insight